COMPANY

Calder Biosciences Inc.

HQ: Brooklyn, NY source · calderbiosciences.com ↗ · Mid-Atlantic

Also known as Calder Biosciences · 11 sources

Keywords: vaccine infectious disease

Location: Brooklyn, NY · source · Oct 15, 2026

Profile checked Oct 10, 2026

11NIH grants

NIH awards 11

Annual award amounts. Total $6.8M.

Mar 23, 2022 NIH award 5R44AG064107-04 FY2022: $984,686 awarded for that fiscal year; activity R44 (SBIR); PI YONDOLA, MARK; recipient as written: CALDER BIOSCIENCES, INC., BROOKLYN, NY. An RSV Prefusion F Vaccine that Overcomes source ↗
Mar 4, 2021 NIH award 5R44AG064107-03 FY2021: $989,026 awarded for that fiscal year; activity R44 (SBIR); PI YONDOLA, MARK; recipient as written: CALDER BIOSCIENCES, INC., BROOKLYN, NY. An RSV Prefusion F Vaccine that Overcomes source ↗
Feb 12, 2020 NIH award 4R44AG064107-02 FY2020: $939,591 awarded for that fiscal year; activity R44 (SBIR); PI YONDOLA, MARK; recipient as written: CALDER BIOSCIENCES, INC., BROOKLYN, NY. An RSV Prefusion F Vaccine that Overcomes source ↗
Nov 27, 2019 NIH award 5R44AG059371-05 FY2020: $887,615 awarded for that fiscal year; activity R44 (SBIR); PI YONDOLA, MARK; recipient as written: CALDER BIOSCIENCES, INC., BROOKLYN, NY. A Universal Flu Vaccine Based On Conformat source ↗
Aug 14, 2019 NIH award 6R44AG059371-04 FY2019: $374,928 awarded for that fiscal year; activity R44 (SBIR); PI YONDOLA, MARK; recipient as written: CALDER BIOSCIENCES, INC., BROOKLYN, NY. A Universal Flu Vaccine Based On Conformat source ↗
Jul 12, 2019 NIH award 6R44AI112124-05 FY2017: $98,819 awarded for that fiscal year; activity R44 (SBIR); PI YONDOLA, MARK; recipient as written: CALDER BIOSCIENCES, INC., BROOKLYN, NY. Dityrosine Locked Prefusion F Protein: A Pa source ↗
Jun 21, 2019 NIH award 5R43AI140941-02 FY2019: $299,955 awarded for that fiscal year; activity R43 (SBIR); PI YONDOLA, MARK; recipient as written: CALDER BIOSCIENCES, INC., BROOKLYN, NY. An adjuvant for an RSV prefusion F vaccine source ↗
May 10, 2019 NIH award 1R44AG064107-01 FY2019: $299,740 awarded for that fiscal year; activity R44 (SBIR); PI YONDOLA, MARK; recipient as written: CALDER BIOSCIENCES, INC., BROOKLYN, NY. An RSV Prefusion F Vaccine that Overcomes source ↗
Jul 5, 2018 NIH award 1R43AI140941-01 FY2018: $299,787 awarded for that fiscal year; activity R43 (SBIR); PI YONDOLA, MARK; recipient as written: CALDER BIOSCIENCES, INC., BROOKLYN, NY. An adjuvant for an RSV prefusion F vaccine source ↗
Jan 9, 2018 NIH award 9R44AG059371-02 FY2018: $986,704 awarded for that fiscal year; activity R44 (SBIR); PI YONDOLA, MARK; recipient as written: CALDER BIOSCIENCES, INC., BROOKLYN, NY. A Universal Flu Vaccine Based On Conformat source ↗
Jun 16, 2017 NIH award 5R44AI112124-04 FY2017: $650,899 awarded for that fiscal year; activity R44 (SBIR); PI YONDOLA, MARK; recipient as written: CALDER BIOSCIENCES, INC., BROOKLYN, NY. Dityrosine Locked Prefusion F Protein: A P source ↗